PFE
http://bit.ly/93O06I $PFE Drugmakers Pfizer, Roche Disappoint With Forecasts
PFE
http://bit.ly/c4azSL $PFE Pfizer Misses Estimates, and Shares Slide
PFE
$pfe : Katsenelson likes the company.perfect stock for this economy.http://bit.ly/9pX5Uv #stocks
PFE
$PFE Like California's state govt, it has become place to stash political hacks & retreads in between elections. http://bit.ly/dxvQeT
PFE
Pfizer Inc $PFE Somewhat Down. Allens acts for Pfizer on divestment of animal health assets: http://bit.ly/d9eVLw
PFE
Pfizer Inc $PFE Somewhat Down. Chartpoppers.com releases Investment Analysis on Bristol Mye: http://bit.ly/aKk9Jz
PFE
Pfizer Inc $PFE Somewhat Down. BRIEF: Bristol-Myers freezing salaries: http://bit.ly/8X4WDG
PFE
Pfizer Inc $PFE Somewhat Down. BRIEF: Bristol-Myers freezing salaries: http://bit.ly/92Invt
PFE
$PFE, sell / short @ market,1st target $16.92, use a stop close only order above $19.26; Selling March $20 calls also warranted.
PFE
@drpdtapp $DNA's Avastin was also approved in renal cancer. All on top of $PFE's Sutent, Torisel and $ONY Nexavar
PFE
$PFE seeing lots of shares trading. http://tinyurl.com/ykw6x86
PFE
$PFE RT @ChristianeTrue @MattD19: Kindler took chance & stood on 1 side of aisle.Unfortunately,may not pay off Via @WSJ http://bit.ly/bC
PFE
RT @reutersBenHir: Will cutting research kill or cure Big Pharma? http://tinyurl.com/yc4kee8 $GSK $AZN $PFE
PFE
Will cutting research kill or cure Big Pharma? http://tinyurl.com/yc4kee8 $GSK $AZN $PFE
PFE
Trust evaporates after Pfizer's Q4 erns. RT @Jim_Edwards Wall Street furious about $PFE's numbers games. http://bit.ly/9LRDsm
PFE
Pfizer Inc $PFE Not Moving. MARKET WATCH: Global stocks close sideways on investor cauti: http://bit.ly/aQ1Tkq
PFE
Pfizer Inc $PFE Not Moving. MARKET WATCH: Global stocks close sideways on investor cauti: http://bit.ly/96eLsr
PFE
Pfizer Inc $PFE Moderately Down, Lost over 3%. Drug adopted by Pfizer OK'd: Xiaflex treats progressive: http://bit.ly/aBXhr8
PFE
spreads, but smaller does not so much. Possible to arbitrage $64B $WYE/$PFE transaction for abt 40% annualizd rates return. $SGP/$MRK was
PFE
RT @MaverickNY - RT @mhuckman: On an ugly day for the stock market Dow components Pfizer $PFE finished down 3%, Merck $MRK off 4% & J&am
PFE
RT @mhuckman: On an ugly day for the stock market Dow components Pfizer $PFE finished down 3%, Merck $MRK off 4% & J&J $JNJ -1.5%.
PFE
Berkowitz on Pharma (shifting from D to O) $PFE http://bit.ly/cBQw88
PFE
Pos dvlpmnt for nwly diag GBM patients - RT @ChristianeTrue @mhuckman $PFE $QGEN to develop EGFRvIII companion test 4 $CLDX/$PFE vaccine
PFE
RT @mhuckman: Pfizer & Qiagen $PFE $QGEN hook up on brain cancer diagnostic to see who might respond to experimental Celldex/PFE tmt. $C
PFE
On an ugly day for the stock market Dow components Pfizer $PFE finished down 3%, Merck $MRK off 4% & J&J $JNJ -1.5%.
PFE
RT @mhuckman: Pfizer & Qiagen $PFE $QGEN hook up on brain cancer diagnostic to see who might respond to experimental Celldex/PFE tmt. $C
Pfizer Inc. - PFE Insiders
No Insiders
We have no insiders for Pfizer right now.
Know someone who is an insider on Pfizer Inc.?
Let us know.
Pfizer Inc. - PFE information
Pfizer Inc. engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. Its Pharmaceutical segment offers Lipitor for elevated cholesterol levels in the blood; Norvasc for hypertension; Caduet for cardiovascular events; Chantix/Champix for smoking cessation; Lyrica for neuropathic pain; Geodon/Zeldox, a psychotropic agent; and Aricept for Alzheimer?s disease. It also provides Celebrex for arthritis pain, and inflammation and acute pain; Vfend for esophageal candidiasis and blood stream infections; Zyvox for bacterial infections; and Selzentry/Celsentri for adults infected with only CCR5-tropic HIV-1 detectable. In addition, this segment provides Viagra for erectile dysfunction; Detrol and Toviaz for overactive bladder; Camptosar for metastatic colorectal cancer; Sutent, an oral multi-kinase inhibitor; Xalatan/Xalacom for open-angle glaucoma and ocular hypertension; and Genotropin for growth disorders. The company?s Animal Health segment offers parasiticides, anti-inflammatories, antibiotics, vaccines, antiemetics, and anti-obesity agents. It also provides Revolution/Stronghold for dogs and cats; Rimadyl for pain and inflammation associated with canine osteoarthritis and soft tissue orthopedic surgery; Clavamox/Synulox for skin and soft tissue infections; RespiSureOne/StellamuneOne to prevent pneumonia in swine; Bovi-Shield Gold for reproductive and respiratory protection; Dectomax, an injectable and pour-on formulations; Draxxin, an antibiotic for infections in cattle and swine; and Excede to treat infections in dairy cows, beef cattle, and swine. Pfizer Inc. also involves in contract manufacturing and bulk pharmaceutical chemicals businesses. It serves doctors, nurse practitioners, physician assistants, pharmacists, hospitals, pharmacy benefit managers, managed care organizations, and government agencies. The company was founded in 1849 and is headquartered in New York, New York....
www.pfizer.com
116,500 Employees
Founded in 1849
PFIZER INC (PFE:New York)
LAST $14.93 USD
CHANGE TODAY -0.16 -1.06%
VOLUME 2.7M
As of 9:44 AM 07/30/10 All times are local (Market data is delayed by at least 15 minutes).
Snapshot of PFIZER INC (PFE)
|
OPEN
$15.02
|
PREVIOUS CLOSE
$15.09
|
|
|
DAY HIGH
$15.02
|
DAY LOW
$14.90
|
|
|
52 WEEK HIGH
01/20/10 - $20.36
|
52 WEEK LOW
07/1/10 - $14.00
|
|
|
MARKET CAP
120.8B
|
AVERAGE VOLUME 10 D
48.3M
|
|
|
EPS TTM
$2.13
|
SHARES OUTSTANDING
8.1B
|
|
|
EX-DATE
08/4/10
|
P/E TTM
7.0x
|
|
|
DIVIDEND
$0.72
|
DIVIDEND YIELD
4.52%
|
|
| K = Thousands M = Millions B = Billions | ||
related news
Business events scheduled for the coming month
AP Digital - 07/29/2010 6:32 PM ET
Business events scheduled for the coming week
AP Digital - 07/29/2010 6:31 PM ET
Most active New York Stock Exchange-traded stocks
AP Digital - 07/29/2010 6:04 PM ET
*Final Glance: Pharmaceuticals companies
AP Digital - 07/29/2010 6:03 PM ET
Midday Glance: Pharmaceuticals companies
AP Digital - 07/29/2010 1:49 PM ET
Key developments for PFIZER INC (PFE)
Pfizer Inc. Presents at Clinical Trials MENA, Sep-26-2010 through Sep-29-2010
07/27/2010
Pfizer Inc. Presents at Clinical Trials MENA, Sep-26-2010 through Sep-29-2010. Venue: Mvenpick Hotel, Jumeirah Beach, Dubai, United Arab Emirates. Presentation Date & Speakers: Sep-26-2010, Alaa Assem, Director, Strategic Public Affairs & Policy - Middle East, Baher Massoud, Regional Head, Medical & Clinical Affairs. Sep-27-2010, Alaa Assem, Director, Strategic Public Affaris & Policy - ME Region. Sep-28-2010, Baher Massoud, Regional Head Medical & Clinical Affairs.
Alaboratorios Almirall SA Signs an Agreement with Pfizer to Market Conbriza
07/26/2010
Laboratorios Almirall SA reached an agreement with Pfizer Inc. to market Conbriza, an osteoporosis treatment drug, in Spain. Almirall said that the deal is important for the company reinforcing its core business over the next years.
Pfizer Inc. Presents at 5th Annual Congress on Clinical Supply Chain Management, Jul-29-2010 09:30 AM
07/26/2010
Pfizer Inc. Presents at 5th Annual Congress on Clinical Supply Chain Management, Jul-29-2010 09:30 AM. Venue: Hyatt Regency, 102 Carnegie Center, Princeton, NJ 08540, United States. Speakers: Lynn Conway, Senior Principal Scientist.
PFE Competitors
| Company | Last | Change |
| Bayer AG | €43.62 EUR | -0.88 |
| Johnson & Johnson | $57.43 USD | -0.40 |
| Kraft Foods Inc | $28.99 USD | -0.125 |
| Novartis AG | SFr.50.75 CHF | -0.25 |
| Roche Holding AG | SFr.135.10 CHF | -1.20 |
| Market data is delayed at least 15 minutes. | ||
Industry Analysis
| Valuation | PFE | Industry Range |
| Price/Earnings | 14.1x |
|
| Price/Sales | 2.2x |
|
| Price/Book | 1.4x |
|
| Price/Cash Flow | 10.5x |
|
| TEV/Sales | 1.0x |
|
|
PFE |
||
|
PFE transactions
| Type Date |
Target |
|
Merger/Acquisition
May 28, 2010 |
Pfizer Inc., Swine Vaccine Business |
|
Merger/Acquisition
April 8, 2010 |
Cap de Paris Office Building |
|
Merger/Acquisition
March 8, 2010 |
Pfizer Inc., Manufacturing Facility in Sligo |
Pfizer Inc. - PFE news
Economic Growth Uncertain, Focus Instead on Investment Strategy
2010-07-30 07:23:16
Quote: Included in this group will be Dow components Pfizer (PFE -Tuesday), Proctor & Gamble (PG - Tuesday), and Kraft Foods (KFT -Thursday).The July ISM manufacturing survey and June construction spending will bethe first economic reports published; both are scheduled for release onMonday. Tuesday features June personal spending and income, the JuneNational Association of Realtors pending home sales index, June factoryorders and July motor vehicle sales. The July ADP employment report andthe July ...Read article
Editor of Viagra Article Unwittingly Reveals Nabokovian Protagonist Sympathies
2010-07-29 04:21:44
Keywords: PATENT,extension,pfizer,VIAGRA,Heh,PFE
Quote: But sometimes the Post goes a wee bit too far. Like today’s headline:“A Kiddie Viagra May Get Pfizer a Patent Extension.”Kiddie? Viagra? Extension?! I feel like I should go to jail just saying those three words in succession.Anyway, the headline aside, the point of the article is fairly fascinating, and yes, it hinges on the fact that Pfizer (PFE) is planning to sell a children’s form of Viagra “to treat a rare lung disorder as a humanitarian gesture-- in exch...Read article
The Truth About $100,000 Cancer Drugs
2010-07-29 04:21:43
Keywords: Medicine, Pharmacuticals, Health Care, Drugs, Drug Companies, Hospitals, Health Insurance
Quote: Then they go on to describe hard-working researchers at companies like Amgen or Pfizer or Novartis who are racing to cure a dire disease.
Over at the New Yorker, Atul Gawande has a great story that focuses on more typical dying patients. You can guess what happens in his story: The drugs fail most of the time. Patients often end up spending their last days in the hospital hooked up to all sorts of life support machines. Doctors keep trying more and more treatments up to and sometimes be...Read article
AstraZeneca Q2 profits up 22 pct
2010-07-29 04:21:39
Keywords: AstraZeneca Q2 profits up 22 pct, azn,bmy,pfe,san, earnings
Quote: With global sales of $9.1 billion in 2009, Plavix was the world's second-best selling drug behind Pfizer Inc.'s cholesterol drug Lipitor.Eli Lilly & Co. launched its own drug, Effient, last summer, but it has faced an uphill climb with sales of $22.9 million in the last quarter.The approval from the FDA committee came despite revelations earlier this week that study results in the U.S. did not match the positive reports from abroad. An international, 18,000-patient study conducted by AstraZeneca...Read article
Health Care Stocks Hospitalized, But Recovering
2010-07-28 05:44:21
Keywords: U.S. Markets, U.S. Equities, Health, Health Care, Medical, Medicine, Phamra, Pharmaceuticals, Biotechnology, Glenn Novarro, Jeff Jonas, Second Quarter, Elections, Reform
Quote: Pfizer(PFE -news-people) has dropped 20%, Medtronic(MDT -news-people) 17%, and Johnson & Johnson(JNJ -news-people) 10%, while Merck(MRK -news-people) is off 4% and Eli Lilly(LLY -news-people) 1%.
Eight Health Care Stocks On The Mend
"It was at the beginning of the year that portfolio managers started scaling back their exposure to heath care, and they were correct to do so, because when the April results came any company related to the pharmaceutical market had to lower their estimates becau...Read article
Merck and Sanofi name CEO of animal medicine unit
2010-07-28 05:44:20
Keywords: Merck and Sanofi name CEO of animal medicine unit, mrk,pfe,san,sgp
Quote: That's well ahead of the leader, Pfizer Inc.'s Fort Dodge unit, which has about 20 percent of the market.Animal health products are an attractive market because sales are growing at a steady 5 percent a year and products generally are not subject to generic competition. In addition, companies have more freedom to set prices without pressure from insurance plans.Merial sells two widely used pet medicines, flea-and-tick blocker Frontline and chewable heartworm preventer Heartgard. Intervet sells P...Read article
Shionogi-ViiV Healthcare LLC Presents Positive Data on Investigational Once-Daily Integrase Inhibitor at International AIDS Conference
2010-07-22 12:26:28
Keywords: Shionogi-ViiV Healthcare LLC Presents Positive Data on Investigational Once-Daily Integrase Inhibitor at International AIDS Conference, gsk,pfe
Quote: Factors that may affect GSK' s operations are described under 'Risk Factors' in the 'Business Review' in the company's Annual Report on Form 20-F for 2009.Pfizer disclosure notice: Pfizer assumes no obligation to update any forward-looking statements contained in this release as a result of new information or future events or developments.This release contains forward-looking information about Pfizer, GlaxoSmithKline and ViiV Healthcare and about the prospects of the companies, including revenue...Read article
Glaxo AIDS drug may have edge after promising data
2010-07-22 12:26:25
Keywords: Pharmaceuticals - diversified,Pharmaceuticals (sub-industry),United Kingdom,Western Europe,Europe,Pharmaceuticals - generic and speciality,Japan,Asia,United States of America,Chemicals,Biotechnology,Austria,Healthcare,Pharmaceuticals and biotechnology,Sci
Quote: Dominique Limet, chief executive of ViiV Healthcare, the
majority-owned Glaxo company that combines its HIV operations
with those of Pfizer (PFE.N), said he was confident '572 would
compete well against rival integrase inhibitors. "It is very potent, we have less resistance problems, it's a
once-a-day formulation, and this is a product tha......Read article
CBOE most active puts and calls
2010-07-22 12:26:23
Keywords: United States of America,Equities,
Quote: These are the most active calls and puts
as of 10:30 a.m.CBOE TOP TEN MOST ACTIVE CALLS - Equity OptionsExpiryStrikeSeriesLastNetSecurityDatePriceVolumePriceChange
--------------------------------------------------------------Bank of Ameri 1/22/201117.5040,1510.41000.0500Bank of Ameri 1/22/201115.0020,4491.05000.0800Citigroup1/21/20127.5010,6610.23000.0000Xerox Corp1/22/20119.009,1251.07000.3800Micron Tech9/18/20109.008,0780.40000.1300Ford Motor Co 7/23/201012.007,3470.27000.1800Pfizer Inc8/21/2...Read article
Pfizer to Offer Free Public Access to Mental Health Assessment Tools to Improve Diagnosis and Patient Care
2010-07-22 12:26:23
Keywords: Pfizer to Offer Free Public Access to Mental Health Assessment Tools to Improve Diagnosis and Patient Care, pfe
Quote: Â http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO )http://www.newscom.com/cgi-bin/prnh/20100416/PFIZERLOGO )"By providing unrestricted access, Pfizer is encouraging broader usage of these important patient assessment aids, which we know will help many healthcare providers and their patients," said Freda C. Lewis-Hall, M.D., senior vice president and chief medical officer at Pfizer. Â "We are listening to the needs of the mental health community and doing what we can to provide the tool...Read article
Wall Street Ends the Day Higher
2010-07-21 05:46:05
Keywords: Mergers & Acquisitions, Investment Banking, I PO, I.P.O.s, IPOs, Offerings, Private Equity, Hedge Funds, Venture Capital, Legal, The New York Times, Andrew Ross Sorkin, Andrew Sorkin, DealBook, deal maker, Wall street, wall st., Goldman Sachs, Goldman Sa
Quote: Shares of the health care company Johnson & Johnson initially dropped 1.7 percent after it reported flat earnings but lowered its outlook because of repeated recalls.
It closed down 99 cents at $58.58.
Pfizer declined 18 cents to $14.55. Shares of Merck were down 14 cents at $35.66.
Economic data also remained weak. On Tuesday, the Department of Commerce reported that construction starts on residential buildings declined in June to the lowest level since October as the sector struggled with ...Read article
UPDATE - Glaxo takes new AIDS drug into final-stage tests
2010-07-21 05:46:05
Keywords: Pharmaceuticals - diversified,Pharmaceuticals (sub-industry),United Kingdom,Western Europe,Europe,Pharmaceuticals - generic and speciality,Japan,Asia,United States of America,Chemicals,Health and medicine,Science; technology,Austria,Healthcare,Pharmaceuti
Quote: Read article
UPDATE - Pfizer stops pain drug trials at FDA request
2010-07-20 09:16:16
Keywords: Pharmaceuticals - diversified,Pharmaceuticals (sub-industry),United States of America,Health and medicine,Regulation and enforcement,Healthcare,Pharmaceuticals and biotechnology,General News,Nature Society and Science,Business activities,Company News item
Quote: Mon Jul 19, 2010 5:41pm EDT
* Tanezumab back pain, diabetic nerve pain trials halted * Move follows June suspension of osteoarthritis trials * FDA requests suspensions over safety concerns NEW YORK, July 19 (Reuters) - Pfizer Inc (PFE.N) said on
Monday it has suspended chronic pain studies of its
experimental drug tanezumab at the request of the U.S. Food and
Drug Administration over safety concerns. The move, which put the breaks on studies of the drug for
low back pain and diabetic nerve pain...Read article
Pfizer halts third study of experimental pain drug
2010-07-20 09:16:14
Keywords: Pfizer halts third study of experimental pain drug, pfe
Quote: (AP) -- Drugmaker Pfizer Inc. has stopped patient tests of an experimental drug for two types of pain at the request of federal regulators, just weeks after halting its testing in arthritis patients.Pfizer was testing tanezumab in patients with chronic low back pain and with painful nerve damage from diabetes complications. Both were late-stage studies. For now, the two studies won't add new patients and will have study participants stop taking their pills.They were part of a program of nearly 2...Read article
Glaxo, Pfizer JV opens HIV pipeline to generic cos
2010-07-19 02:28:19
Keywords: Pharmaceuticals - diversified,Pharmaceuticals (sub-industry),United Kingdom,Western Europe,Europe,United States of America,Pharmaceuticals - generic and speciality,Japan,Asia,Emerging countries,Africa,Healthcare,Pharmaceuticals and biotechnology,Company N
Quote: Fri Jul 16, 2010 9:00am EDT
* Generic firms offered licences for all ViiV medicines * Royalty-free offer includes current and pipeline products * Covers 69 poor countries, including all sub-Saharan Africa LONDON, July 16 (Reuters) - ViiV Healthcare, GlaxoSmithKline
(GSK.L) and Pfizer's (PFE.N) joint venture company for AIDS
drugs, is opening its entire product line-up to generic
drugmakers working in the world's poorest countries. The announcement, on the eve of next week's international
AIDS co...Read article
AIDS drug cocktails halve new HIV cases in study
2010-07-19 02:28:16
Keywords: United States of America,Canada,Health and medicine,Science; technology,Pharmaceuticals - diversified,Pharmaceuticals (sub-industry),United Kingdom,Western Europe,Europe,Chemicals,General News,Nature Society and Science,Healthcare,Pharmaceuticals and biot
Quote: Drugmakers include Gilead (GILD.O),
GlaxoSmithKline (GSK.L), Pfizer (PFE.N), Merck & Co (MRK.N),
Bristol-Myers Squibb (BMY.N) and Abbott Laboratories (ABT.N). The Canadian team, led by Julio Montaner at the British
Columbia Centre for Excellence in Vancouver, analysed data on
HAART and looked at viral load of HIV patients -- the level of
virus in their bodies -- and at new HIV diagnoses in the
province, where residents get free HIV care.HAART involves treatment with three or more AIDS drugs,...Read article
Sun Pharma says US court denies motion on Protonix
2010-07-19 02:28:15
Keywords: Pharmaceuticals - generic and speciality,Pharmaceuticals (sub-industry),Emerging countries,India,Asia,Pharmaceuticals - diversified,United States of America,Denmark,Nordic Countries,Europe,Judicial processes/court cases/court decisions,Legislation,Regulat
Quote: court had denied its motion to reverse a jury
verdict of infringement against the Indian firm on Pfizer's
(PFE.N) Protonix acid reflux drug patent that the jury had said
was valid. In a statement dated July 17, Sun said it was not
prohibited from selling the drug before the expiry of Pfizer's
marketing exclusivity in January 2011, as its other claims
concerning the validity of the patents, including patent
misuse, were still pending. In April, a jury in the U.S. District Court for New Jersey
had...Read article
A Scary Idea: Pre-emptive Brain Scans For Alzheimer's.
2010-07-16 04:02:07
Keywords: Medicine, Pharmacuticals, Health Care, Drugs, Drug Companies, Hospitals, Health Insurance
Quote: Yet the committee seems in a rush to promote new tests before they are fully validated.
Undoubtedly, plaque brain scans might help companies like Eli Lilly, Pfizer, Elan and Johnson & Johnson trying to test Alzheimer's drugs. They could be a big boon for companies like General Electric and tiny Avid Radiopharmaceuticals working on compounds that could be used find Alzheimer's brain plaques using brain scans. An Eli Lilly official was on the panel that made the new recommendations.
USC ...Read article
US study may be ideal test for Alzheimer's drugs
2010-07-16 04:02:03
Keywords: Pharmaceuticals (sub-industry),Health and medicine,Pharmaceuticals - diversified,United States of America,Pharmaceuticals - generic and speciality,Ireland,Western Europe,Europe,Japan,Asia,Regulation and enforcement,Insurance (industry group),Financials,Ge
Quote: Current Alzheimer's drugs, including Eisai Co (4523.T) and
Pfizer Inc's (PFE.N) Aricept, or donezepil, and Forest
Laboratories' (FRX.N) Namenda, or memantine, treat symptoms,
but so far nothing has been shown to improve memory and
thinking in people with the disease. Bateman said that may be because they are testing too late
in the disease, and he thinks the DIAN study, in which patients
are sure to get the disease, may offer a way to test these
drugs earlier, before symptoms appear. "It's nearl...Read article
A Delay in Protalix's Uplyso FDA Review Is Not a Disaster
2010-07-15 07:23:23
Quote: It, too,had faced some regulatory scrutiny for its novel manufacturing processfor Uplyso,a proprietary plant cell expressed recombinant form of humanglucocerebrosidase, already partnered with Pfizer (PFE) (Protalix'swoes continue with Uplyso setback, February 2, 2010).TheIsraeli company’s shares continue to languish well below the two-yearhigh of $12.14 they touched November 9, 2009, a month before it brought Pfizer on board tocommercialise Uplyso worldwide outside of Israel.After Protalix...Read article